Echinacea 250 mg
En vente sur le marché américain (selon le DSLD)
BIOVEA, food supplement from the US market
Echinacea 250 mg (BIOVEA), a food supplement au code-barres 689076002639, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- BIOVEA
- Barcode
- 689076002639
- Form
- Capsule
- One serving
- 1 vegetarian capsule
- Servings
- up to 8 servings per day
- Other ingredients (in English, as written)
- Rice Flour, Cellulose, Microcrystalline Cellulose, Magnesium Stearate
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Echinacea Blend (Echinacea purpurea) | Plant | 250 mg |
| Echinacea purpurea (Echinacea purpurea) | Plant | not stated |
| Echinacea angustifolia (Echinacea angustifolia) | Plant | not stated |
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Echinacea 250 mg
Entered into DSLD on 25 June 2014. Retirée du marché américain le 3 March 2021 (selon le DSLD).Same active composition.
Official label: Echinacea 250 mg
Entered into DSLD on 25 June 2014. Retirée du marché américain le 3 March 2021 (selon le DSLD).Same active composition.
Official label: Echinacea 250 mg
Entered into DSLD on 25 June 2014. Retirée du marché américain le 1 May 2015 (selon le DSLD).Same active composition.
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Echinacea Blend
Read the warning, when it applies and the studies cited
ECHINACEA - ECHINACEA PURPUREA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, or an immune system disorder (EMA 2015; Gardner and McGuffin 2013; Brinker 2010).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications to suppress the immune system (Brinker 2010; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: Preparations containing herb top.
Stop use if hypersensitivity/allergy occurs (MHRA 2018; EMA 2015; Kligler 2003; WHO 1999).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Echinacea angustifolia
Read the warning, when it applies and the studies cited
ECHINACEA- ECHINACEA ANGUSTIFOLIA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, or an immune system disorder (Gardner and McGuffin 2013; Brinker 2010).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications to suppress the immune system (Brinker 2010; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : BIOVEA
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.